Question 1

Does Ubs own CURX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Ubs holds 1,506 shares of CURX (Curanex Pharmaceuticals), worth $400.

Question 2

How many shares of CURX does Ubs own?

Accepted Answer

As of its Q2 2026 13F, Ubs holds 1,506 shares of CURX (Curanex Pharmaceuticals).

Question 3

What is Ubs' CURX position worth?

Accepted Answer

As of its Q2 2026 13F, Ubs' CURX position is worth $400.

Question 4

Is Ubs buying or selling CURX?

Accepted Answer

In Q2 2026, Ubs reduced its CURX position by 6,489 shares (-81.2%).

Question 5

When did Ubs first buy CURX?

Accepted Answer

Ubs first reported CURX in its Q3 2025 13F and has listed it in 4 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	1,506	-81.2%	$400	0.0%	$0.27	0
2026-Q1	Decreased	7,995	-38.5%	$4,085	0.0%	$0.46	0
2025-Q4	Decreased	12,991	-79.9%	$4,300	0.0%	$0.34	0
2025-Q3	New	64,516	-	$46,451	0.0%	$0.79	31

CURX4 quarters

CURX
4 quarters